Stockreport

Enlivex Announces Positive Interim Data Readout from a Phase I/II Trial Evaluating Allocetra in End-Stage Knee Osteoarthritis [Yahoo! Finance]

Enlivex Therapeutics Ltd. - Ordinary Shares  (ENLV) 
PDF Three-month data readout showed a significant reduction in pain and a favorable safety profile Pain reduction: patients reported an average pain reduction of 64% from [Read more]